-+ 0.00%
-+ 0.00%
-+ 0.00%

BioRestorative Therapies Announces $2M Stock Repurchase Program

Benzinga·06/17/2025 13:25:57
Listen to the news

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $2 million of its outstanding common stock through June 16, 2026.